Cipta Sarana Medika Tbk. vs Indo-Rama Synthetics Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Indo-Rama Synthetics Tbk. trades at Rp2,030 (market cap 1.33T, 79.1K 24h volume). The key difference: Indo-Rama Synthetics Tbk. is far larger — about 8.4× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 79.1K). Which is the better fit depends on your goals.
| DKHH | INDR | |
|---|---|---|
Market Cap | 158.12B | 1.33T |
Volume | 8.21M | 79.1K |
Lot | 82.15K | 791 |
Turnover | 515.2M | 165.69M |
Average Price | 62.72 | 2,094.65 |
Value | 515.2M | 165.69M |
Indicative Equilibrium Price | 63 | 2,030 |
Indicative Equilibrium Volume | 1.33K | 18 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT. Indo-Rama Synthetics Tbk (the Company) was established within the framework of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial DeedNo. 21 dated April 3, 1974, of Gustaaf Hoemala Soangkoepon Loemban Tobing, SH, public notary in Jakarta.
Read more on INDR →